During the past decade, Alexian Brothers Neurosciences Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 16 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alexian Brothers Neurosciences Institute" #1 sponsor was "Genentech, Inc." with 6 trials, followed by "Biogen" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Novartis" with 4 trials sponsored and "TauRx Therapeutics Ltd" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alexian Brothers Neurosciences Institute" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alexian Brothers Neurosciences Institute" are "Alzheimer's Disease" (24 trials), "Alzheimer Disease" (8 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Alzheimer Disease (AD)" (1 trials) and "Alzheimer Disease, Early Onset" (1 trials). Many other conditions were trialed in "Alexian Brothers Neurosciences Institute" in a lesser frequency.

Most popular intervention types in "Alexian Brothers Neurosciences Institute" are "Drug" (38 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Crenezumab" (3 trials) and "Aducanumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alexian Brothers Neurosciences Institute" are 39 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Alexian Brothers Neurosciences Institute". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Alexian Brothers Neurosciences Institute, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Alexian Brothers Neurosciences Institute, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".